Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 74Terminated 27Unknown 15Withdrawn 8Active not recruiting 6Recruiting 5Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 17Breast Neoplasms 14Rectal Neoplasms 12Nasopharyngeal Carcinoma 8Stomach Neoplasms 5Triple Negative Breast Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Adenocarcinoma 3Recurrence 2Pancreatic Neoplasms 2HER2-positive Gastric Cancer 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Spinocerebellar Degenerations 1Rectal Neoplasms Malignant 1Rectal Cancer Patients 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1Pancreatic Cancer Non-resectable 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Metastatic Breast Cancer in the Brain 1MSI-H Colorectal Cancer 1Locally Advanced Rectal Cancer (LARC) 1

Interventions

Gemcitabine 20130-nm albumin-bound paclitaxel 8irinotecan sucrosofate 7Oxaliplatin 6Leucovorin 6Fluorouracil 6Taxes 5Drug Therapy 5Albumin-Bound Paclitaxel 4toripalimab 3S 1 (combination) 3Paclitaxel 3Injections 3surufatinib 2camrelizumab 2Specimen Handling 2Pemetrexed 2Pancreaticoduodenectomy 2Irinotecan 2Exercise 2Capecitabine 2Blood Specimen Collection 2zimberelimab 1sintilimab 1potassium oxonate 1pembrolizumab 1nimotuzumab 1netrin-1 inhibitor NP137 1gimeracil 1folfirinox 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Neoplasms × Capecitabine × Clear all
NCT06571461 2024-08-27

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

CSPC Ouyi Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
408 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06217042 2024-01-22

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Fudan University

Phase 3 Not yet recruiting
524 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡